At ESMO 2019, starting on Friday 27 September, promising results will be presented from some studies exploring the use of liquid biopsies in colorectal cancer (CRC), According to Daily Reporter Associate Editor Rodrigo Dienstmann, from Vall d'Hebron University Hospital, Barcelona, Spain, they will show the potential of using ctDNA in deliver precision medicine.
Relevant findings in molecular stratified treatments in colorectal cancer
